IN-VITRO ACTIVITIES OF FREE AND LIPOSOMAL DRUGS AGAINST MYCOBACTERIUM AVIUM-M-INTRACELLULARE COMPLEX AND MYCOBACTERIUM-TUBERCULOSIS

We compared MICs and MBCs of various free- and liposome-incorporated antimicrobial agents against several patient isolates of Mycobacterium avium-M. intracellulare complex and certain American Type Culture Collection strains of M. avium, M. intracellulare, and Mycobacterium tuberculosis. Seven of 19 agents were selected for incorporation into liposomes. The MICs of these agents for 50 and 90% of isolates tested (MIC(50)s and MIC(90)s, respectively) ranged from 0.5 to 62 mu g/ml. Members of the M. avium-M. intracellulare complex were resistant to killing by most of the other agents tested in the free form. However, clofazimine, resorcinomycin A, and PD 117558 showed complete killing of bacteria at concentrations ranging from 8 to 31 mu g/ml, represented as MBC(90)s. Among the liposome-incorporated agents, clofazimine anti resorcinomycin A had the highest killing effects (MBC(90)s, 8 and 16 mu g/ml, respectively). Furthermore, both free and liposome-incorporated clofazimine had equivalent growth-inhibitory and killing effects on all American Type Culture Collection strains of M. avium, M. intracellulare, and M. tuberculosis tested. These results show that the antibacterial activities of certain drugs, particularly those of clofazimine and resorcinomycin, were maintained after the drugs were incorporated into liposomes.